IRIS Accounts Production v25.3.0.601 12545426 director 1.4.24 31.3.25 31.3.25 14.10.25 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125454262024-03-31125454262025-03-31125454262024-04-012025-03-31125454262023-03-31125454262023-04-012024-03-31125454262024-03-3112545426ns15:EnglandWales2024-04-012025-03-3112545426ns14:PoundSterling2024-04-012025-03-3112545426ns10:Director12024-04-012025-03-3112545426ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3112545426ns10:SmallEntities2024-04-012025-03-3112545426ns10:Audited2024-04-012025-03-3112545426ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3112545426ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3112545426ns10:FullAccounts2024-04-012025-03-3112545426ns10:RegisteredOffice2024-04-012025-03-3112545426ns5:CurrentFinancialInstruments2025-03-3112545426ns5:CurrentFinancialInstruments2024-03-3112545426ns5:ShareCapital2025-03-3112545426ns5:ShareCapital2024-03-3112545426ns5:FurtherSpecificReserve1ComponentTotalEquity2025-03-3112545426ns5:FurtherSpecificReserve1ComponentTotalEquity2024-03-3112545426ns5:RetainedEarningsAccumulatedLosses2025-03-3112545426ns5:RetainedEarningsAccumulatedLosses2024-03-3112545426ns5:PlantMachinery2024-04-012025-03-3112545426ns5:ComputerEquipment2024-03-3112545426ns5:ComputerEquipment2024-04-012025-03-3112545426ns5:ComputerEquipment2025-03-3112545426ns5:ComputerEquipment2024-03-3112545426ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3112545426ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3112545426ns5:RetainedEarningsAccumulatedLosses2024-03-3112545426ns5:FurtherSpecificReserve1ComponentTotalEquity2024-03-3112545426ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-311254542612024-04-012025-03-31
REGISTERED NUMBER: 12545426 (England and Wales)















AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

SIRIONLABS LIMITED

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SIRIONLABS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Ajay Agrawal



REGISTERED OFFICE: 11 Cursitor Street
London
EC4A 1LL



REGISTERED NUMBER: 12545426 (England and Wales)



AUDITORS: Smartax Limited
Chartered Certified Accountants and
Statutory Auditors
38 Station Road
Harrow
Middlesex
HA2 7SE



BANKERS: J P Morgan Chase Bank
National Association
25 Bank Street
Canary Wharf
London
E14 5JP



ACCOUNTANTS: Auctus Accountants Ltd
2 Churchill Court
58 Station Road
North Harrow
HA2 7SA

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 16,766 18,152

CURRENT ASSETS
Debtors 5 725,702 555,996
Cash at bank 102,624 233,132
828,326 789,128
CREDITORS
Amounts falling due within one year 6 419,264 552,675
NET CURRENT ASSETS 409,062 236,453
TOTAL ASSETS LESS CURRENT
LIABILITIES

425,828

254,605

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Share option reserve 8 255,368 227,112
Retained earnings 8 169,460 26,493
425,828 254,605

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 October 2025 and were signed by:





Ajay Agrawal - Director


SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

SirionLabs Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts are prepared in sterling, which is the functional currency of the entity.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is generated from recharges to the parent company with an applied profit markup.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33.33% on cost

Share-based payments
Sirion Labs is part of a Group equity-settled share incentive scheme. The fair value of share options granted under the scheme is measured at the date of the grant using "The black scholes model".

The fair value of the estimated number of options and awards that are expected to be vested is expensed to income statement on a straight-line basis over the period that employees' services are rendered with a corresponding increase in the share option reserve.

Options not vested within six months of leaving employment are forfeited and cancelled are credited to the income statement in the year of forfeiture with a corresponding reduction in the share option reserve.

The options are recorded on an aggregate basis.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2024 - 14 ) .

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2024 37,570
Additions 11,935
At 31 March 2025 49,505
DEPRECIATION
At 1 April 2024 19,418
Charge for year 13,321
At 31 March 2025 32,739
NET BOOK VALUE
At 31 March 2025 16,766
At 31 March 2024 18,152

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Amounts owed by group undertakings 640,817 504,446
Other debtors 84,885 51,550
725,702 555,996

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade creditors 48,396 22,038
Taxation and social security 99,917 180,729
Other creditors 270,951 349,908
419,264 552,675

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


7. EMPLOYEE STOCK OWNERSHIP PLAN (ESOP)

The movements of ESOPS during the period is shown below:


No. of options

2025 2024

Brought forward 330,500 646,500
Granted during the year 20,000 98,000
Exercised during the year --- (12,500)
Lapsed during the year (212,000) (401,500)
_______ _________
Carried forward 138,500 330,500
________ _________
The weighted average exercise price of the options carried forward at the year end is £2.08 (2024 - £2.71)

8. RESERVES
Share
Retained option
earnings reserve Totals
£    £    £   

At 1 April 2024 26,493 227,112 253,605
Profit for the year 142,967 142,967
Share option movement - 28,256 28,256
At 31 March 2025 169,460 255,368 424,828

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

S Rajan CTA FCCA ACA (Senior Statutory Auditor)
for and on behalf of Smartax Limited

Material uncertainty related to going concern.

We draw attention to Note 12, which indicates that the company is reliant on the financial support from its parent company. As stated in Note 12, these conditions, along with other matters as set forth in Note 12, indicate that a material uncertainty exists that may cast significant doubt on the company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

10. PENSION COMMITMENTS

The amount recognised in the profit and loss as an expense in relation to defined contribution plans was £87,833 (2024 - £72,520). As at the period end contributions totalling £12,553 (2024 - £23,810) were payable.

11. RELATED PARTY DISCLOSURES

In accordance with FRS 102 paragraph 1AC.35, the company has taken advantage of the exemption from disclosing transactions with wholly owned group undertakings.

SIRIONLABS LIMITED (REGISTERED NUMBER: 12545426)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


12. GOING CONCERN

The company derives its revenue on a cost plus basis from the parent company SirionLabs PTE. LTD. As such it is entirely reliant on the parent company for its financial support. The directors have reviewed the current results of the company together with the financial position of the parent company, and after making enquiries will continue to receive the necessary support from SirionLabs PTE. LTD for the foreseeable future and at least for twelve months from the date of signing.

Accordingly, the directors continue to adopt the going concern basis in preparing the accounts. As such the accounts do not contain adjustments that would be required if the company was unable to continue as a going concern.

13. POST BALANCE SHEET EVENTS

No matters or circumstances have arisen since the year-end date that significantly affect, or are likely to affect the operations, results or state of affairs of the Company for the foreseeable future.

14. ULTIMATE CONTROLLING PARTY

The immediate parent company is SirionLabs PTE. LTD, a company registered in Singapore whose registered office is situated at 120, Robinson road, 03-12 Singapore, 068914.


In the opinion of the directors, there is no ultimate controlling party for the company.